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Abstracts / Osteoarthritis and Cartilage 20 (2012) S10–S53 S45knockout (KO) and wild type (WT) mice, or WT mouse chondrocytes
treated with AMPK pharmacologic activator AICAR were subjected to
Western blot analyses for expression of PGC-1a, FOXO3a, SOD2, catalase
and thioredoxin.
Results: NF-kB activation (Ser536 phosphorylation p65 NF-kB), NO
generation and MMP-3 expression induced by IL-1b and TNFa were
enhanced in primary human knee articular chondrocytes with knock-
down of PGC-1a or FOXO3a. In addition, decreased expression of PGC-
1a and FOXO3a, correlated with decreased expression of SOD2, catalase
and thioredoxin, was observed in AMPKa1 KO chondrocytes, compared
with WT chondrocytes. Conversely, activation of AMPK by AICAR
signiﬁcantly increased expression of SOD2, catalase and thioredoxin in
chondrocytes.
Conclusions: Activation of AMPK-PGC-1a and AMPK-FOXO3a pathways
maintain the cellular redox balance in articular chondrocytes by up-
regulating anti-oxidant genes, and inhibit chondrocyte catabolic
responses to inﬂammatory cytokines.
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TOWARDS GENE-BASED ANALYSIS OF GENOME-WIDE ASSOCIATION
OSTEOARTHRITIS DATA
A. Gonzalez 1, C. Rodriguez-Fontenla 1, M. Calaza 1, E. Evangelou 2,
J.J. Gomez-Reino 1. Translation Research in Europe Applied
Technologies for Osteoarthritis (TreatOA)1Hosp. Clinico Univ.rio de
Santiago, Santiago de Compostela, Spain; 2Univ. of Ioannina Sch. of
Med., Ioannina, Greece
Purpose: New tools are being developed to extract additional infor-
mation from Genome-Wide Associations studies (GWAS) beyond the
comparisons involving a SNP at a time. A promising area involves
generating a single global statistic for each gene by combining associ-
ation data from each SNP in its locus, hence called Gene-Based Analysis
(GBA). This approach will be particularly useful for genes with multiple
susceptibility polymorphisms of small effect and for genes with several
low frequency susceptibility variants of relative high effect. However,
there are still many standing questions that need to be addressed before
GBA could be widely accepted. We have explored the feasibility of using
GBA for the elucidation of OA genetics.
Methods: We used an approach that accounts for linkage disequilib-
rium between SNPs. This involved the use of statistical tests that take
into account dependence between SNPs deﬁned by the LD structure of
each gene. In addition, we have incorporated information about genetic
recombination for the deﬁnition of each gene. Gene coordinates were
taken from a human genome database (UCSC hg18). This information
was combined with the deCODE recombination maps to deﬁne gene
boundaries [1]. Overlapping genes were combined in a single locus.
About 2.5 million SNPs and their respective p values were taken from
a meta-analysis of 9 OA GWAS [2]. Their positions in the genes were
obtained fromHapMap Phase II+III (rel28) as well as the genotypes used
to obtain the pairwise r squaredmatrix of LD in each locus. This analysis
was done with PLINK. Four different statistics were used to combine p
values from all SNPs in each gene: linear combination test (LCT),
quadratic test (QT), decorrelation test (DT) and Fisher test with an
approximation for dependent p values (FT) [3,4]. All analyses were done
in a cluster of Unix nodes (SVG.CESGA.es).
Results: Combination of the genomic coordinates of 18022 human
genes and the recombination (sex-averaged) map gave 7125 non-
overlapping loci. These loci contained from 1 to 61 geneswith amean of
2.5 genes. Median size of these loci was 170 Kb (IQR 90-300 Kb). First
analyses showed that SNPs with minor allele frequency (MAF) below 5
% disproportionally contributed to the increased complexity of the LD
pattern and to a reduction of the power of statistics accounting for LD.
Therefore, the GBA was performed in two parts: SNPs with MAF over 5
%, with approaches that accounted for LD; and for SNPs withMAF below
5 %, without accounting for LD (not pursued here). For the ﬁrst part, 1.23
million SNPs with p values from the OA GWAS meta-analysis and MAF
larger than 5 % were contained in the genes (median ¼ 117, IQR 60-216).
A pilot study with 100 randomly chosen genes plus two known OA
susceptibility loci (GDF5 and 7q22) showed that two statistics (LCT and
FT) performed reasonably well. They indentiﬁed the two known loci as
the most associated. The other two statistics did not identify any of
them.
Conclusions: There are still obstacles for the use of GBA to extract more
information from OA GWAS data. We have found that two separate
analyses are required because the low frequency SNPs add too muchcomplexity to analyses accounting for the LD structure of the genes. For
SNPs of MAF over 5 %, we have found that all the process including two
of the described statistics perform reasonable well. The other two tests
still do not work adequately. Concordance between the different
statistics is desirable to increase conﬁdence in the results and we
continue working to obtain it by improving deﬁnition of the LD
structure.
1. Kong A, et al. Nature (2010): 28;467:1099-103.
2. Evangelou E. et al. Unpublished.
3. Luo L, et al. Eur J Hum Genet. (2010);18:1045-53.
4. Kost.J.T, McDermott M.P. Statistics and Probability Letters. (2002); 60:
183-190.
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THE OSTEOARTHRITIS SUSCEPTIBILITY GENE GDF5 IS UNDER
EPIGENETIC REGULATION BY DNA METHYLATION - THE
MOLECULAR INTERPLAY BETWEEN GENETICS AND EPIGENETICS IN
DISEASE RISK
L.N. Reynard, C.M. Syddall, J. Loughlin. Newcastle Univ., Newcastle upon
Tyne, United Kingdom
Purpose: GDF5 is involved in chondrogenesis, synovial joint mainte-
nance and repair, and is essential for normal skeletal, bone and joint
development. The rs143383 C to T SNP within the GDF5 50UTR is
associated with OA susceptibility and with susceptibility to other
musculoskeletal phenotypes. rs143383 exerts a joint-wide effect on
GDF5 expression, with expression of the OA-associated T allele being
signiﬁcantly reduced relative to the C allele, a phenomenon termed
differential allelic expression (DAE). We have previously reported that
the GDF5 promoter and 5'UTR are subject to DNAmethylation in human
cell lines and in the soft joint tissues meniscus, fat pad, ligament, and
synovium, and that demethylation of speciﬁc CpG dinucleotides within
the 5'UTR is associated with an increase in the DAE of rs143383. In this
study, we performed a focussed and detailed analysis of the methyla-
tion status of the GDF5 locus in cartilage, the principal tissue affected in
OA and one which we have not examined before. Our aims were to (1)
determine if DNA methylation regulates GDF5 expression in chon-
drocytes, and (2) understand how demethylation of speciﬁc CpG sites in
the 5'UTR affects the DAE of rs143383 and thus OA susceptibility.
Methods: Human articular chondrocytes (HACs) were cultured with
5mM of the demethylating agent 5-aza-2’deoxycytidine (AZA), and gene
expression and DNA methylation assessed by qRT-PCR and bisulphite
sequencing. Macroscopically normal cartilage was obtained from OA
patients who had undergone either total hip (n¼11) or total knee
(n¼13) replacement surgery, with cartilage from fractured neck of
femur (NOF, n¼15) patients used as a non-OA control. Genomic DNA
was extracted, bisulphite converted and methylation of the GDF5 locus
analysed by either pyrosequencing or cloning and Sanger sequencing.
Electrophoretic mobility shift assays (EMSAs) were used to analyse how
methylation of the CpG site at +37 located 3bp upstream of rs143383
affected binding of transacting factors to the C and T alleles of this SNP
and whether this affected GDF5 DAE.
Results: GDF5 transcription was signiﬁcantly increased in HACs
exposed to AZA relative to control cells, with the extent of upregulation
varying between patients from 2.3 to 5.4 fold. There were signiﬁcant
differences in the total methylation of the GDF5 locus in cartilage from
NOF, OA hip and OA knee patients, with the GDF5 CpG island being
signiﬁcantly hypomethylated in OA knee (p<0.0005) and hip (p<0.015)
relative to NOF. The GDF5 5'UTR was also hypomethylated in OA knee
cartilage, with the greatest demethylation observed at the +37 and +106
CpG sites; we have previously demonstrated that AZA-induced deme-
thylation of these sites correlates with increased DAE of rs143383 in-
vitro. A more detailed molecular analysis of how the +37 CpG site
upstream of the rs143383 SNP affects DAE of this SNP was performed
using EMSAs. These demonstrated that methylation of the +37 CpG site
reduced binding of protein complexes to the T allele but not the C allele
of rs143383. This suggests that the AZA induced increase in DAE of
rs143383 we observed previously is the result of increased binding of
a repressor(s) to the T allele of rs143383 caused by the demethylation at
the +37 CpG site.
Conclusions: The methylation status of the +37 CpG site has a signiﬁ-
cant effect on the binding of transcriptional repressors to the T allele of
rs143383, demonstrating that DNA methylation modulates the genetic
effect of the OA-associated SNP rs143383 on GDF5 gene expression. The
inter-individual variability in DAE of rs143383 can therefore be
Abstracts / Osteoarthritis and Cartilage 20 (2012) S10–S53S46accounted for by differences in DNA methylation of the +37 CpG site
that could inﬂuence the penetrance of rs143383 in susceptibility to OA
and in other common musculoskeletal diseases.
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ALLELIC EXPRESSION ANALYSIS IN PATIENT TISSUES OF THE
OSTEOARTHRITIS AND OF THE LUMBAR DISC HERNIATION
SUSCEPTIBILITY LOCI THAT MAP TO COL11A1
A.W. Dodd, E.V. Raine, L.N. Reynard, J. Loughlin. Newcastle Univ.,
Newcastle upon Tyne, United kingdom
Purpose: The arcOGEN genome-wide association scan (GWAS) has
generated evidence of association to OA of single nucleotide poly-
morphism (SNP) rs2615977 fromwithin intron 31 of COL11A1. This gene
codes for the a1 polypeptide chain of type XI collagen and has long been
considered a strong candidate for OA susceptibility, based on the
important structural role of type XI collagen in the cartilage extracel-
lular matrix and on the observation that penetrant mutations of
COL11A1 can cause Stickler's syndrome, which is a rare disease char-
acterized by severe early-onset secondary OA. Furthermore, a common
exonic SNP of COL11A1, rs1676486, has been reported to be associated
with lumbar disc herniation (LDH) in a Japanese population. LDH, like
OA, is a degenerative musculoskeletal condition whose prevalence
increases with age. Unlike rare diseases, many common complex traits
are mediated by cis-acting regulatory polymorphisms that inﬂuence
gene transcription or transcript stability, resulting in allelic expression
imbalance. The LDH SNP rs1676486 is an example of such a poly-
morphism, with the LDH-associated T allele of the SNP mediating
decreased stability of the COL11A1 transcript relative to the C allele. In
this study we therefore set out to assess: 1) whether the OA association
to rs2615977 was marking allelic expression imbalance of COL11A1 and
2) whether the detrimental effect that rs1676486 has on COL11A1
transcript expression in LDH is also observed in the cartilage of OA
patients.
Methods: Using RNA extracted from the cartilage of OA patients who
had undergone elective joint replacement surgery, we assessed
whether either SNP correlated with COL11A1 allelic expression by: 1)
measuring COL11A1 expression by quantitative PCR and then strati-
fying the data by genotype at each SNP in turn and 2) accurately
discriminating and quantifying the mRNA synthesized from both
alleles of each SNP, using allelic-quantitative PCR performed on
heterozygous patients. We studied a total of 73 male and female
patients, who had undergone either a hip or a knee replacement.
Linear regression was used to assess whether COL11A1 expression
relative to genotype differed signiﬁcantly from the null, whilst a 2-
tailed Mann-Whitney exact test was used to assess the signiﬁcance of
any allelic differences.
Results: We found no evidence for a correlation between COL11A1
expression levels and genotype at either SNP, nor were there any
correlations when the patients were stratiﬁed by the joint replaced
(all P-values were greater than 0.05). This stratiﬁcation analysis is
vulnerable to the natural variability in gene expression between
individuals, which can decrease its sensitivity and accuracy. For
example, in individuals of the same genotype we observed up to
a 250-fold difference in COL11A1 expression. The direct measurement
of allelic output is not vulnerable to such effects. In our allelic
expression analysis we found no evidence that genotype at the OA
associated SNP rs2615977 correlated with allelic expression imbal-
ance. However, we detected a complete correlation between allelic
expression imbalance and genotype at the LDH associated SNP
rs1676486: in all of the patients that we studied who were hetero-
zygous for this SNP the LDH associated T allele produced signiﬁcantly
less transcript than the C allele, with an average allelic ratio of 0.36
and P-value less than 0.0001. When we tested this SNP for association
in the arcOGEN GWAS of 7,410 cases and 11,009 controls, we did not
however detect any compelling evidence of association to OA (all
P-values were greater than 0.01).
Conclusions: In the tissues that we have studied our data does not
support the OA association signal at COL11A1, which is marked by SNP
rs2615977, as mediating an effect on the expression of the COL11A1
mRNA. However, the LDH SNP rs1676486 does mediate an effect on
COL11A1 expression in the same direction as that seen in LDH, but this
is not a risk factor for OA. Overall, COL11A1 can tolerate polymorphism
in its expression in hip or knee cartilage without this acting as a risk
factor for OA, something not seen in LDH.77
A GENETIC ANALYSIS OF OSTEOARTHRITIS OF THE KNEE IN NORTH
AMERICAN CAUCASIANS: RESULTS FROM THE OSTEOARTHRITIS
INITIATIVE AND JOHNSTON COUNTY OSTEOARTHRITIS PROJECT
L.M. Yerges-Armstrong 1, C. Lu 1, M.C. Hochberg 1, B. Mitchell 1,
J.M. Jordan 2, J.B. Renner 2, T. McSherry 3, D.M. Taverna 3,
D. Duggan 3, W.J. Mysiw 4, R. Jackson 4. 1Univ. of Maryland, Baltimore,
MD, USA; 2Univ. of North Carolina, Chapel Hill, NC, USA; 3 TGen,
Pheonix, AZ, USA; 4 The Ohio State Univ., Columbus, OH, USA
Purpose: A strong genetic contribution to osteoarthritis (OA) is widely
recognized although few loci have yet to be robustly associated with
knee OA susceptibility. To identify genes associated with knee OA, we
performed joint analyses across two large North American cohorts with
well-characterized phenotypes of knee OA: the Genetic Components of
Knee OA (GeCKO) Study, an ancillary study from the Osteoarthritis
Initiative (OAI), and the Johnston County (JoCo) Osteoarthritis Project.
Our goals were to 1) attempt replication of 14 single nucleotide poly-
morphisms (SNPs) previously reported in the literature to be associated
with hip or knee OA, and 2) conduct an agnostic genome-wide asso-
ciation (GWA) analysis.
Methods: Cases had at least one knee with deﬁnite radiographic OA,
deﬁned as the presence of deﬁnite osteophytes (OARSI grade 1)
regardless of the presence of joint space narrowing (equivalent to
Kellgren-Lawrence [KL] grade >2). Controls were required to be free of
radiographic evidence of OA in both knees (i.e., no evidence of both
osteophytes and joint space narrowing, or KL grade¼ 0). Based on these
deﬁnitions, there were 1,920 and 761 Caucasian cases in the GeCKO-OAI
and JoCo cohorts, and 885 and 634 controls, respectively, included in
the analyses. The 14 SNPs selected for replication were identiﬁed
through a review of candidate gene and GWA studies in the literature.
Genotyping was carried out on the Illumina 2.5M and 1M arrays in
GeCKO-OAI and JoCo, respectively. Association analyses were carried
out separately in each cohort with adjustments for age and sex.
Results: None of the 14 previously reported genetic variants for OA
achieved even nominal signiﬁcance (p<0.05) with knee OA in the
GeCKO-OAI sample, despite a power to detect odds ratios of 1.17 or
greater. A hypothesis-free GWA analysis was then carried out in the
GeCKO-OAI sample on the 1.3M SNPs that passed genotype cleaning
ﬁlters. No SNPs were associated with knee OA at GWA levels of statis-
tical signiﬁcance (P < 5x10-8). However, a total of 155 SNPs, repre-
senting 54 different chromosome regions, were suggestively associated
with knee OA at a threshold of P < 10-4. We then tested these SNPs for
association with knee OA in cases and controls from the JoCo Study. Of
the 87 SNPs available for replication in JoCo, none were signiﬁcantly
associated with knee OA at a nominal P < 0.01. At our tested levels of
signiﬁcance (i.e., P < 10-4 in GeCKO-OAI and P < 0.01 in JoCo), we
estimated that our sample would have 80% power to detect SNPs having
odds ratios of 1.34 or higher among all SNPs tested in GeCKO-OAI and
for the subset of SNPs tested for replication in JoCo for disease allele
frequencies of 0.20 or greater.
Conclusions: Our ﬁndings support the polygenic nature of the genetic
contribution to knee OA and the likelihood that contributing loci are
likely to have very small effects. While it is potentially challenging to
harmonize OA case and control deﬁnitions between different studies,
ongoing meta-analyses may best be able to accommodate the complex
genetic architecture of OA.
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THE IDENTIFICATION OF TRANS-ACTING FACTORS THAT
DIFFERENTIALLY REGULATE THE EXPRESSION OF GDF5 VIA THE
OSTEOARTHRITIS ASSOCIATED SNP RS143383
C.M. Syddall, L.N. Reynard, D.A. Young, J. Loughlin. Newcastle Univ.,
Newcastle upon Tyne, United Kingdom
Purpose: A single nucleotide polymorphism (SNP), rs143383, in the
growth and differentiation factor 5 (GDF5) gene has been widely
studied, with the T-allele of the SNP being associated with an increased
risk of osteoarthritis (OA) and of a number of other common muscu-
loskeletal diseases. The effect of the SNP on gene function has been
investigated with the T-allele producing less GDF5 transcript in
comparison with the C-allele, both in-vitro and in-vivo, a phenomenon
known as allelic expression imbalance (AEI). The aim of this study was
to identify the trans-acting regulatory factors responsible for this
rs143383-mediated GDF5 AEI.
